Your browser doesn't support javascript.
loading
What Factors Influence In-Hospital Mortality Following Aseptic Revision Total Hip Arthroplasty? : A Single-Center Analysis of 13,203 Patients.
Karlidag, Taner; Budin, Maximilian; Luo, T David; Dasci, M Fatih; Gehrke, Thorsten; Citak, Mustafa.
Affiliation
  • Karlidag T; Department of Orthopaedic Surgery, Helios ENDO-Klinik Hamburg, Hamburg, Germany.
  • Budin M; Department of Orthopaedic Surgery, Helios ENDO-Klinik Hamburg, Hamburg, Germany.
  • Luo TD; Department of Orthopaedic Surgery, Helios ENDO-Klinik Hamburg, Hamburg, Germany; Orthopaedics Northeast Fort Wayne, IN, USA.
  • Dasci MF; Department of Orthopaedic Surgery, Helios ENDO-Klinik Hamburg, Hamburg, Germany.
  • Gehrke T; Department of Orthopaedic Surgery, Helios ENDO-Klinik Hamburg, Hamburg, Germany.
  • Citak M; Department of Orthopaedic Surgery, Helios ENDO-Klinik Hamburg, Hamburg, Germany. Electronic address: mcitak@gmx.de.
J Arthroplasty ; 2024 Sep 02.
Article in En | MEDLINE | ID: mdl-39233101
ABSTRACT

BACKGROUND:

Revision total hip arthroplasty (rTHA) is associated with an extended surgical period, an increased hospitalization period, expanded blood loss, and high mortality rates. The purpose of the current study was to assess the risk factors that contribute to in-hospital mortality following aseptic rTHA.

METHODS:

We performed a retrospective examination of the medical records of all patients who underwent elective rTHA surgery at our tertiary referral arthroplasty center between March 1996 and March 2019. The study involved a group of 13,203 patients, including 70 who expired during hospitalization and 13,133 in the control group. Baseline characteristics, medical history, comorbidities, and surgery-related parameters of the patients were recorded. Logistic regression analyses were performed to examine the association between independent variables and in-hospital mortalities, which were presented as odds ratios (OR) and confidence intervals (CI).

RESULTS:

Patient factors associated with in-hospital mortality included hepatitis C (OR 75.5, 95% CI 3.5 to 1,625.2), chronic obstructive pulmonary disease (OR 30.7, 95% CI 6.5 to 145.7), rheumatoid arthritis (OR 28.9, 95% CI 3.8 to 218.5), history of myocardial infarction (OR 24.9, 95% CI 4.4 to 140.8), history of cerebrovascular disease (OR 23.1, 95% CI 3.8 to 142), congestive heart failure (OR 18.9, 95% CI 3.8 to 94.2), and diabetes mellitus (OR 10.2, 95% CI 2.4 to 42.6). Surgical factors included the history of multiple prior revisions (OR 1.75, 95% CI 1.1 to 2.7), postoperative blood transfusion (OR 2.8, 95% CI 1.1 to 7.3), and decreased preoperative hemoglobin (OR 2.3, 95% CI 1.7 to 3.1).

CONCLUSION:

Several patient-related and intraoperative factors significantly increased the risk of in-hospital mortality following aseptic revision THA. Vigilance and close perioperative monitoring are essential for patients undergoing this complex surgery.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Arthroplasty Journal subject: ORTOPEDIA Year: 2024 Document type: Article Affiliation country: Germany Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Arthroplasty Journal subject: ORTOPEDIA Year: 2024 Document type: Article Affiliation country: Germany Country of publication: United States